3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
5
Neoplasms
3
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Posterior Fossa Ependymal Tumor
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms by Site
1
Metabolic Diseases
1
Insulin Resistance
1
Infertility
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Drug-drug Interaction,SHR3680
1
Diabetes Mellitus, Type 2
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Breast Diseases
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
cabozantinib
4
Nivolumab
2
Ipilimumab
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
atezolizumab
1
Surveys and Questionnaires
1
Ropivacaine
1
Pluvicto
1
Methods
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Axitinib
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Metformin
×
30 days
×
Clear all
No trials found.